Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

Fig. 1

Kaplan-Meier survival curves of A-B vs. C-D class mHAP-II, mHAP, and HAP risk scores at the first (a-c) and second (d-f) rounds of TACE. Patients with A-B class risk scores showed significantly better survival than those with C-D class risk scores at the first and second TACE rounds. mHAP, modified hepatoma arterial-embolization prognostic; TACE, trans-arterial chemoembolization

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us